Investors & Media

Press Releases



All Releases
View Summary TG Therapeutics, Inc. Announces Data Presentations at the 57th American Society of Hematology Annual Meeting From Ongoing Clinical Studies in Patients With Non-Hodgkins Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Dec 6, 2015
PDF 24.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Recaps Schedule of Data Presentations at the 57th American Society of Hematology Annual Meeting
Dec 4, 2015
PDF 19.0 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Third Quarter 2015 Financial Results and Business Update
Nov 9, 2015
PDF 119.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 57th American Society of Hematology Annual Meeting
Nov 5, 2015
PDF 20.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2015 Financial Results and Business Update
Nov 4, 2015
PDF 11.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the Ladenburg Thalmann 2015 Healthcare Conference
Sep 25, 2015
PDF 13.9 KB Add to Briefcase
View Summary TG Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA for the First Phase 3 Clinical Trial of Its Proprietary Combination Regimen of TG-1101 (ublituximab) in Combination With TGR-1202 for Patients With Chronic Lymphocytic Leukemia (CLL)
Sep 17, 2015
PDF 112.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Launches Phase 1/2 "Triple-Therapy" Study With TGR-1202 + TG-1101 + the PD-1 Checkpoint Inhibitor Pembrolizumab in Patients With Advanced Chronic Lymphocytic Leukemia (CLL) at the University of Pennsylvania's Abramson Cancer Center
Sep 9, 2015
PDF 111.0 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Participate in Upcoming Investment Conferences in September
Sep 8, 2015
PDF 14.2 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Second Quarter 2015 Financial Results and Business Update
Aug 10, 2015
PDF 119.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Host Conference Call on Second Quarter 2015 Financial Results and Business Update
Aug 5, 2015
PDF 14.7 KB Add to Briefcase
View Summary Updated Results From Phase 2 Clinical Trial of TG-1101 (Ublituximab) in Combination With Ibrutinib Confirms Robust Clinical Activity With a Favorable Safety Profile in Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL)
Jun 18, 2015
PDF 23.2 KB Add to Briefcase
View Summary TG Therapeutics to Present Clinical Data on TG-1101 and TGR-1202 at the 20th Congress of the European Hematology Association and the 13th International Congress on Malignant Lymphoma
Jun 11, 2015
PDF 47.7 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the Jefferies 2015 Healthcare Conference
Jun 2, 2015
PDF 15.5 KB Add to Briefcase
View Summary TG Therapeutics Announces the Triple Combination of TG-1101, TGR-1202 and Ibrutinib is Safe and Highly Active in Patients With Advanced B-Cell Malignancies
Jun 1, 2015
PDF 66.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Presentations of Its Proprietary Combination of TG-1101 Plus TGR-1202 as Well as TGR-1202 as a Single Agent in Ongoing Phase I/Ib Dose Escalation Clinical Studies
May 31, 2015
PDF 111.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Recaps Schedule of Clinical Data Presentations at the 51st Annual Meeting of the American Society of Clinical Oncology
May 29, 2015
PDF 112.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Clinical Data Presentations at the Upcoming 51st Annual Meeting of the American Society of Clinical Oncology
May 13, 2015
PDF 19.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces First Quarter 2015 Financial Results and Business Update
May 4, 2015
PDF 62.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the Deutsche Bank 40th Annual Health Care Conference
May 1, 2015
PDF 13.9 KB Add to Briefcase
Showing 81-100 of 193 Page: 1 2 3 4 5 6 7 8 9 10  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase